Xenotransplantation of islets enclosed in agarose microcapsule carrying soluble complement receptor 1

Biomaterials

Volumn 33, Issue 32, 2012, Pages 8075-8081

  Luan, Nguyen Minh ^a   Iwata, Hiroo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Agarose; Islet transplantation; Microencapsulation; Soluble complement receptor 1 (sCR1); Xenotransplantation

Indexed keywords

AGAROSE; ISLET TRANSPLANTATION; MICROENCAPSULATION; SOLUBLE COMPLEMENT RECEPTOR 1 (SCR1); XENOTRANSPLANTATION;

ENCAPSULATION; GLUCOSE; GRAFTING (CHEMICAL); MAMMALS;

GRAFTS;

AGAROSE; BIOMATERIAL; COMPLEMENT COMPONENT C3B RECEPTOR; GLUCOSE; SOLUBLE COMPLEMENT RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENCAPSULATION; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; MALE; MICROCAPSULE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALS; CAPSULES; CELLS, CULTURED; CHO CELLS; CRICETINAE; GLUCOSE TOLERANCE TEST; HUMANS; IMMOBILIZED PROTEINS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED ACI; RECEPTORS, COMPLEMENT; SEPHAROSE; TRANSPLANTATION, HETEROLOGOUS;

MUS; RATTUS;

EID: 84865540934     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.048     Document Type: Article

References (40)

1. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
2. Robertson R.P. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004, 350:694-705.
3. Narang A.S., Mahato R.I. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev 2006, 58:194-243.
4. Hansson M., Madsen O.D. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy. Curr Opin Investig Drugs 2010, 11:417-425.
5. Wagner R.T., Lewis J., Cooney A., Chan L. Stem cell approaches for the treatment of type 1 diabetes mellitus. Transl Res 2010, 156:169-179.
6. Aguayo-Mazzucato C., Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 2010, 6:139-148.
7. Pierson R.N., Dorling A., Ayares D., Rees M.A., Seebach J.D., Fishman J.A., et al. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation 2009, 16:263-280.
8. Yang Y.G., Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007, 7:519-531.
9. Dufrane D., Gianello P. Pig islet xenotransplantation into non-human primate model. Transplantation 2008, 86:753-760.
10. Ekser B., Cooper D.K. Overcoming the barriers to xenotransplantation: prospects for the future. Expert Rev Clin Immunol 2010, 6:219-230.
11. Bach F.H., Robson S.C., Winkler H., Ferran C., Stuhlmeier K.M., Wrighton C.J., et al. Barriers to xenotransplantation. Nat Med 1995, 1:869-873.
12. Walport M.J. Complement. First of two parts. N Engl J Med 2001, 344:1058-1066.
13. Walport M.J. Complement. Second of two parts. N Engl J Med 2001, 344:1140-1144.
14. Azzi J., Geara A.S., El-Sayegh S., Abdi R. Immunological aspects of pancreatic islet cell transplantation. Expert Rev Clin Immunol 2010, 6:111-124.
15. Nanji S.A., Shapiro A.M. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs 2004, 18:315-328.
16. Min D.I., Monaco A.P. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy 1991, 11:119S-125S.
17. Lim F., Sun A.M. Microencapsulated islets as bioartificial pancreas. Science 1980, 210:908-910.
18. Lacy P.E., Hegre O.D., Gerasimidi-Vazeou A., Gentile F.T., Dionne K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991, 254:1782-1874.
19. Chaikof E.L. Engineering and material considerations in islet cell transplantation. Annu Rev Biomed Eng 1999, 1:103-127.
20. Iwata H., Takagi T., Amemiya H., Shimizu H., Yamashita K., Kobayashi K., et al. Agarose for bioartificial pancreas. J Biomed Mater Res 1992, 26:967-977.
21. Kin T., Iwata H., Aomatsu Y., Ohyama T., Kanehiro H., Hisanaga M., et al. Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic acid mixed gel. Pancreas 2002, 25:94-100.
22. Kobayashi T., Aomatsu Y., Iwata H., Kin T., Kanehiro H., Hisanaga M., et al. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 2003, 75:619-625.
23. Kobayashi T., Aomatsu Y., Iwata H., Kin T., Kanehiro H., Hisanga M., et al. Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice. Cell Transplant 2006, 15:359-365.
24. Cheung C.Y., Anseth K.S. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug Chem 2006, 17:1036-1042.
25. Qi M., Gu Y., Sakata N., Kim D., Shirouzu Y., Yamamoto C., et al. PVA hydrogel sheet macroencapsulation for the bioartificial pancreas. Biomaterials 2004, 25:5885-5892.
26. Qi Z., Shen Y., Yanai G., Yang K., Shirouzu Y., Hiura A., et al. The in vivo performance of polyvinyl alcohol macro-encapsulated islets. Biomaterials 2010, 31:4026-4031.
27. Iwata H., Morikawa N., Fujii T., Takagi T., Samejima T., Ikada Y. Does immunoisolation need to prevent the passage of antibodies and complements?. Transplant Proc 1995, 27:3224-3226.
28. Iwata H., Kobayashi K., Takagi T., Oka T., Yang H., Amemiya H., et al. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J Biomed Mater Res 1994, 28:1003-1011.
29. Morikawa N., Iwata H., Fujii T., Ikada Y. An immuno-isolative membrane capable of consuming cytolytic complement proteins. J Biomater Sci Polym Ed 1996, 8:225-236.
30. Luan N.M., Teramura Y., Iwata H. Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation. Biomaterials 2010, 31:8847-8853.
31. Pruitt S.K., Bollinger R.R. The effect of soluble complement receptor type 1 on hyperacute allograft rejection. J Surg Res 1991, 50:350-355.
32. Pruitt S.K., Kirk A.D., Bollinger R.R., Marsh H.C., Collins B.H., Levin J.L., et al. The effect of soluble complement receptor 1 on hyperacute rejection of porcine xenografts. Transplantation 1994, 57:363-370.
33. Luan N.M., Teramura Y., Iwata H. Immobilization of soluble complement receptor 1 on islets. Biomaterials 2011, 32:4539-4545.
34. Luan N.M., Teramura Y., Iwata H. Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets. Biomaterials 2011, 32:6487-6492.
35. Kato H., Inoue T., Ishii N., Murakami Y., Matsumura M., Seya T., et al. Novel simple method to purify recombinant soluble human complement receptor type 1 (sCR1) from CHO cell culture. Biotechnol Bioproc Eng 2002, 7:67-75.
36. Lacy P.E., Kostianovky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
37. Lee D.Y., Park S.J., Nam J.H., Byun Y. A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation. J Control Release 2006, 110:290-295.
38. Bretzel R.G., Hering B.J., Federlin K.F. Assessment of adult islet preparations. Methods in cell transplantation 1995, 455-464. RG Landes, Austin, TX. C. Ricordi (Ed.).
39. Iwata H., Takagi T., Kobayashi K., Oka T., Tsuji T., Ito F. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J Biomed Mater Res 1994, 28:1201-1207.
40. Huang J., Kim L.J., Mealey R., Marsh H.C., Zhang Y., Tenner A.J., et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999, 285:595-599.